Xtant Medical Holdings (XTNT) Non Operating Interest Expenses (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Non Operating Interest Expenses for 16 consecutive years, with $718000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Non Operating Interest Expenses fell 36.68% year-over-year to $718000.0 in Q4 2025; TTM through Dec 2025 was $3.7 million, a 11.75% decrease from a year earlier, with the FY2025 full-year figure at $3.7 million, down 11.75% from the prior year.
• Non Operating Interest Expenses was $718000.0 for Q4 2025 at Xtant Medical Holdings, down from $904000.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $1.2 million in Q3 2024 and troughed at $1000.0 in Q1 2021.
• A 5-year average of $672800.0 and a median of $739000.0 in 2023 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses sank 99.91% in 2021 and soared 35800.0% in 2022, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $466000.0 in 2021, then gained by 6.22% to $495000.0 in 2022, then surged by 65.25% to $818000.0 in 2023, then soared by 38.63% to $1.1 million in 2024, then sank by 36.68% to $718000.0 in 2025.
• The last three Non Operating Interest Expenses figures came in at $718000.0 (Q4 2025), $904000.0 (Q3 2025), and $1.0 million (Q2 2025), per Business Quant data.